 | | Vol. 12.07 – 23 February, 2023 |
| |
|
|
| Scientists reported that intranasal delivery of recombinant insulin-like growth factor binding proteins (IGFBP2) protects aged mice from weight loss and demonstrated antifibrotic effects after bleomycin lung injury.
[Cell Reports Medicine] |
|
|
|
 | | PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Researchers found that T-cell immunoglobulin and mucin domain-containing molecule 4 (TIM-4) promoted growth and proliferation of lung cancer cells by the oxidative phosphorylation pathway.
[Cell Death & Disease] |
|
|
|
| Using single-cell RNA sequencing, investigators demonstrated that both infected and uninfected cells upregulated antiviral genes with nearly identical kinetics, while uninfected non-ciliated cells were the primary source of proinflammatory chemokines.
[Mucosal Immunology] |
|
|
|
| Scientists found that PM2.5-induced BMAL1 inhibition resulted in up-regulation of p53 protein in bronchial epithelial cells, then increased-p53 promoted autophagy
[Cell Communication And Signaling] |
|
|
|
| Investigators presented the structure and function of TMEM16A, the pathogenesis of pulmonary hypertension, and highlighted the role and mechanism of TMEM16A in pulmonary hypertension.
[Cardiovascular Pathology] |
|
|
|
| Researchers established cytotoxicity models of human lung epithelial cells and bronchial epithelial cells exposed to benzofluoranthene for 24h to reveal the mechanisms.
[Journal Of Applied Toxicology] |
| |
|
|
| Scientists developed a highly controlled non-tumorigenic human bronchial epithelial cell system expressing four ALK fusions found in NSCLC.
[Proceedings Of The National Academy Of Sciences Of The United States Of America] |
|
|
|
| Researchers analyzed both RNA sequencing data and clinical outcomes obtained from public databases to identify (i) NLR family CARD domain containing 3 (NLRC3) as a tumor suppressor in lung adenocarcinoma (LUAD) and (ii) its predictive value for the likelihood of patient responsiveness to immunotherapy.
[Scientific Reports] |
|
|
|
| Scientists examined the potential functions of excision repair cross-complementing group 6 (ERCC6) in NSCLC.
[Biochemistry And Cell Biology] |
|
|
|
|
| Investigators review how the epithelium contributes to the development of Th2 sensitization to allergens and asthma with a “type 2-high” signature, in both murine models and human studies of this asthma endotype.
[European Journal Of Immunology] |
|
|
|
| The authors describe the therapeutic strategies integrating medical and radiation oncology in patients with metastatic NSCLC adenocarcinoma with central nervous system involvement and EGFR activating mutations or ALK rearrangement.
[La Radiologica Medica] |
|
|
|
|
| BiomX, Inc. announced positive results from Part 1 of the Phase Ib/IIa trial evaluating the Company’s novel phage cocktail, BX004, for the treatment of chronic pulmonary infections caused by Pseudomonas aeruginosa in patients with cystic fibrosis.
[BiomX, Inc.] |
|
|
|
|
| March 5 – 9, 2023
Banff, Alberta, Canada |
|
|
|
|
|
| | University of Virginia – Charlottesville, Virginia, United States |
|
|
|
| | University of Louisville – Louisville, Kentucky, United States |
|
|
|
| | STEMCELL Technologies – Vancouver, British Columbia, Canada |
|
|
|
| | IRCCS Candiolo Cancer Institute – Turin, Italy |
|
|
|
| | Pompeu Fabra University – Barcelona, Spain |
|
|
|
|
Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News
